Viewing nowCombinationAmlokande Tablet 16/5 mg (Candesartan Cilexetil, S-Amlodipine Besilate)
Candesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 202503324 · Approved 2025.12.19
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with candesartan cilexetil or S-amlodipine. This helps to stabilize blood pressure and reduce the risk of complications due to hypertension. Such treatment aids in improving cardiovascular health and enhancing overall quality of life.
The recommended dose is 1 tablet once daily, taken with water with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (candesartan cilexetil or S-amlodipine (amlodipine)). However, if blood pressure is not adequately controlled with monotherapy using the individual components, a direct switch to this medicine may be considered as follows. - 8/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/2.5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, S-amlodipine 5 milligrams (amlodipine 10 milligrams), or this medicine 16/2.5 milligrams. Patients taking candesartan cilexetil and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. • Patients with renal impairment: Since the recommended initial dose of candesartan cilexetil for patients with renal impairment is 4 milligrams once daily, it is not advisable to use this medicine as initial therapy. • Patients with hepatic impairment: Since the recommended initial dose of candesartan cilexetil for patients with mild or moderate hepatic impairment is 2 milligrams once daily, it is not advisable to use this medicine as initial therapy.
• Children: Use of this medicine is not recommended for adolescents and children 18 years of age or younger because its safety and efficacy have not been established.
This drug can cause serious harm to the fetus, especially in the second and third trimesters of pregnancy, so treatment should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to patients with specific allergic reactions or with a history of severe liver dysfunction, severe kidney dysfunction, or angioedema. Elderly patients, patients with hyperkalemia, those with impaired liver function, and patients with severe hypotension should be observed carefully when using this drug. Since this medication lowers blood pressure, caution is required in patients with hypotension or heart failure to avoid exacerbating symptoms. It is important to regularly check serum potassium levels and kidney function during treatment with this drug to monitor for abnormalities. This medication may interact with other antihypertensive agents, diuretics, potassium supplements, etc., so consultation with medical personnel is essential. If symptoms such as dizziness, headache, swelling, or skin rash occur during treatment, medical personnel should be informed immediately. Women who are pregnant or breastfeeding should not take this medicine, and if it is absolutely necessary to take it, they should consult with a specialist prior to the decision. This drug is not recommended for use in children or adolescents under 18 years of age as its safety and efficacy have not been established. In case of overdose, severe hypotension, dizziness, tachycardia, etc., may occur, so the dosage should be strictly followed and medical attention should be sought immediately if any adverse symptoms arise. When storing this medication, keep it out of reach of children, and do not transfer it to a different container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy of the drug for a longer period.
White, double convex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.